#4: ILC2s and neutrophils
An episode of the Inflammatory Content podcast, hosted by Kellen Cavagnero, Ph.D., titled "#4: ILC2s and neutrophils" was published on February 2, 2020 and runs 26 minutes.
February 2, 2020 ·26m · Inflammatory Content
Summary
In this episode, Kellen covers a topic near and dear to his heart – group two innate lymphoid cells, or ILC2s. Specifically, Kellen discusses the original article titled “Neutrophils restrain allergic airway inflammation by limiting ILC2 function and monocyte–dendritic cell antigen presentation”, which was published in the journal Science Immunology in November 2019 by Dhiren Patel and colleagues.Paper: https://immunology.sciencemag.org/content/4/41/eaax7006/tab-pdfReview: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614509/ (shameless self-promo)To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero). Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.
Episode Description
In this episode, Kellen covers a topic near and dear to his heart – group two innate lymphoid cells, or ILC2s. Specifically, Kellen discusses the original article titled “Neutrophils restrain allergic airway inflammation by limiting ILC2 function and monocyte–dendritic cell antigen presentation”, which was published in the journal Science Immunology in November 2019 by Dhiren Patel and colleagues.
Paper: https://immunology.sciencemag.org/content/4/41/eaax7006/tab-pdf
Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614509/ (shameless self-promo)
To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero).
Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.
Similar Episodes
Apr 2, 2026 ·29m
Feb 5, 2026 ·37m
Sep 4, 2025 ·35m
Jul 30, 2025 ·53m